Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • MPMedical Practitioner
  • MWMidwife
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 11011M ELBASVIR + GRAZOPREVIRelbasvir 50 mg + grazoprevir 100 mg tablet, 28 1 28 3
MPNP 11021C ELBASVIR + GRAZOPREVIRelbasvir 50 mg + grazoprevir 100 mg tablet, 28 1 28 2
MPNP 5290K ELETRIPTANeletriptan 40 mg tablet, 4 1 4 5
MPNP 5291L ELETRIPTANeletriptan 80 mg tablet, 4 1 4 5
MPNP 10206E EMPAGLIFLOZINempagliflozin 10 mg tablet, 30 1 30 5
MPNP 10202Y EMPAGLIFLOZINempagliflozin 25 mg tablet, 30 1 30 5
MPNP 11298P EMPAGLIFLOZIN + LINAGLIPTINempagliflozin 25 mg + linagliptin 5 mg tablet, 30 1 30 5
MPNP 11310G EMPAGLIFLOZIN + LINAGLIPTINempagliflozin 10 mg + linagliptin 5 mg tablet, 30 1 30 5
MPNP 10626G EMPAGLIFLOZIN + METFORMINempagliflozin 5 mg + metformin hydrochloride 500 mg tablet, 60 1 60 5
MPNP 10627H EMPAGLIFLOZIN + METFORMINempagliflozin 5 mg + metformin hydrochloride 1 g tablet, 60 1 60 5
MPNP 10677Y EMPAGLIFLOZIN + METFORMINempagliflozin 12.5 mg + metformin hydrochloride 1 g tablet, 60 1 60 5
MPNP 10633P EMPAGLIFLOZIN + METFORMINempagliflozin 12.5 mg + metformin hydrochloride 500 mg tablet, 60 1 60 5
MPNP 1370D ENALAPRILenalapril maleate 5 mg tablet, 30 1 30 5
MPNP 1368B ENALAPRILenalapril maleate 10 mg tablet, 30 1 30 5
MPNP 1369C ENALAPRILenalapril maleate 20 mg tablet, 30 1 30 5
MPNP 8477E ENALAPRIL + HYDROCHLOROTHIAZIDEenalapril maleate 20 mg + hydrochlorothiazide 6 mg tablet, 30 1 30 5
MPNP 5434B ENOXAPARIN SODIUMenoxaparin sodium 80 mg/0.8 mL injection, 10 x 0.8 mL syringes 2 20 3
MPNP 8263X ENOXAPARIN SODIUMenoxaparin sodium 80 mg/0.8 mL injection, 10 x 0.8 mL syringes 1 10 1
MPNP 5435C ENOXAPARIN SODIUMenoxaparin sodium 100 mg/mL injection, 10 x 1 mL syringes 2 20 3
MPNP 8264Y ENOXAPARIN SODIUMenoxaparin sodium 100 mg/mL injection, 10 x 1 mL syringes 1 10 1
MPNP 8262W ENOXAPARIN SODIUMenoxaparin sodium 60 mg/0.6 mL injection, 10 x 0.6 mL syringes 1 10 1
MPNP 8640R ENOXAPARIN SODIUMenoxaparin sodium 60 mg/0.6 mL injection, 10 x 0.6 mL syringes 2 20 3
MPNP 8558K ENOXAPARIN SODIUMenoxaparin sodium 20 mg/0.2 mL injection, 10 x 0.2 mL syringes 2 20 0
MPNP 8716R ENOXAPARIN SODIUMenoxaparin sodium 20 mg/0.2 mL injection, 10 x 0.2 mL syringes 2 20 3
MPNP 8510X ENOXAPARIN SODIUMenoxaparin sodium 40 mg/0.4 mL injection, 10 x 0.4 mL syringes 2 20 0
MPNP 8639Q ENOXAPARIN SODIUMenoxaparin sodium 40 mg/0.4 mL injection, 10 x 0.4 mL syringes 2 20 3
MPNP 8367J ENTACAPONEentacapone 200 mg tablet, 100 2 200 4
MPNP 8879H EPLERENONEeplerenone 25 mg tablet, 30 1 30 5
MPNP 8880J EPLERENONEeplerenone 50 mg tablet, 30 1 30 5
MPNP 8397Y EPROSARTANeprosartan 400 mg tablet, 28 2 56 5
MPNP 8951D EPROSARTANeprosartan 400 mg tablet, 28 2 56 5
MPNP 5491B EPROSARTANeprosartan 600 mg tablet, 28 1 28 5
MPNP 8447N EPROSARTANeprosartan 600 mg tablet, 28 1 28 5
MPNP 8624X EPROSARTAN + HYDROCHLOROTHIAZIDEeprosartan 600 mg + hydrochlorothiazide 12.5 mg tablet, 28 1 28 5
MPNP 11571B ERTUGLIFLOZINertugliflozin 15 mg tablet, 28 1 28 5
MPNP 11585R ERTUGLIFLOZINertugliflozin 5 mg tablet, 28 1 28 5
MPNP 11575F ERTUGLIFLOZIN + METFORMINertugliflozin 2.5 mg + metformin hydrochloride 500 mg tablet, 56 1 56 5
MPNP 11581M ERTUGLIFLOZIN + METFORMINertugliflozin 2.5 mg + metformin hydrochloride 1 g tablet, 56 1 56 5
MPNP 11568W ERTUGLIFLOZIN + METFORMINertugliflozin 7.5 mg + metformin hydrochloride 500 mg tablet, 56 1 56 5
MPNP 11563N ERTUGLIFLOZIN + METFORMINertugliflozin 7.5 mg + metformin hydrochloride 1 g tablet, 56 1 56 5
MPNP 11578J ERTUGLIFLOZIN + SITAGLIPTINertugliflozin 15 mg + sitagliptin 100 mg tablet, 28 1 28 5
MPNP 11579K ERTUGLIFLOZIN + SITAGLIPTINertugliflozin 5 mg + sitagliptin 100 mg tablet, 28 1 28 5
MPNP 1404X ERYTHROMYCINerythromycin 250 mg enteric capsule, 25 1 25 1
MPNP 2424N ERYTHROMYCIN ETHYLSUCCINATEerythromycin (as ethylsuccinate) 200 mg/5 mL powder for oral liquid, 100 mL 1 1 1
MPNP 2750R ERYTHROMYCIN ETHYLSUCCINATEerythromycin (as ethylsuccinate) 400 mg tablet, 25 1 25 1
MPNP 2428T ERYTHROMYCIN ETHYLSUCCINATEerythromycin (as ethylsuccinate) 400 mg/5 mL powder for oral liquid, 100 mL 1 1 1
MPNP 8700X ESCITALOPRAMescitalopram 10 mg tablet, 28 1 28 5
MPNP 9432K ESCITALOPRAMescitalopram 10 mg tablet, 28 1 28 5
MPNP 8701Y ESCITALOPRAMescitalopram 20 mg tablet, 28 1 28 5
MPNP 9433L ESCITALOPRAMescitalopram 20 mg tablet, 28 1 28 5
MPNP 10181W ESCITALOPRAMescitalopram 20 mg/mL oral liquid, 15 mL 1 1 5
MPNP 10330Q ESOMEPRAZOLEesomeprazole 40 mg enteric capsule, 30 1 30 1
MPNP 10331R ESOMEPRAZOLEesomeprazole 40 mg enteric capsule, 30 1 30 5
MPNP 10295W ESOMEPRAZOLEesomeprazole 20 mg enteric capsule, 30 1 30 1
MPNP 10343J ESOMEPRAZOLEesomeprazole 20 mg enteric capsule, 30 1 30 5
MPNP 3401B ESOMEPRAZOLEesomeprazole 40 mg enteric tablet, 30 1 30 5
MPNP 8601Q ESOMEPRAZOLEesomeprazole 40 mg enteric tablet, 30 1 30 1
MPNP 8600P ESOMEPRAZOLEesomeprazole 20 mg enteric tablet, 30 1 30 5
MPNP 8886Q ESOMEPRAZOLEesomeprazole 20 mg enteric tablet, 30 1 30 1
MPNP 10759G ESOMEPRAZOLE (&) CLARITHROMYCIN (&) AMOXICILLINesomeprazole 20 mg tablet: enteric [14 tablets] (&) clarithromycin 500 mg tablet [14 tablets] (&) amoxicillin 500 mg capsule [28 capsules], 1 pack 1 1 0
MPNP 8738X ESOMEPRAZOLE (&) CLARITHROMYCIN (&) AMOXICILLINesomeprazole 20 mg tablet: enteric [14 tablets] (&) clarithromycin 500 mg tablet [14 tablets] (&) amoxicillin 500 mg capsule [28 capsules], 1 pack 1 1 0
MPNP 9329B ESSENTIAL AMINO ACIDS FORMULAessential amino acids formula powder for oral liquid, 2 x 200 g 6 6 5
MPNP 2027Q ESSENTIAL AMINO ACIDS FORMULA WITH MINERALS AND VITAMIN Cessential amino acids formula with minerals and vitamin C powder for oral liquid, 400 g 5 5 5
MPNP 9385Y ESSENTIAL AMINO ACIDS FORMULA WITH VITAMINS AND MINERALSessential amino acids formula with vitamins and minerals powder for oral liquid, 50 x 12.5 g sachets 4 4 5
MPNP 8274L ESTRADIOLestradiol 2 mg tablet, 56 1 56 2
MPNP 8486P ESTRADIOLestradiol 75 microgram/24 hours patch, 4 1 1 5
MPNP 10203B ESTRADIOLestradiol 10 microgram modified release pessary, 18 1 18 2
MPNP 8126Q ESTRADIOLestradiol 100 microgram/24 hours patch, 4 1 1 5
MPNP 1663M ESTRADIOLestradiol valerate 1 mg tablet, 56 1 56 2
MPNP 8485N ESTRADIOLestradiol 25 microgram/24 hours patch, 4 1 1 5
MPNP 8764G ESTRADIOLestradiol 75 microgram/24 hours patch, 8 1 1 5
MPNP 8140K ESTRADIOLestradiol 50 microgram/24 hours patch, 8 1 1 5
MPNP 8763F ESTRADIOLestradiol 50 microgram/24 hours patch, 8 1 1 5
MPNP 8311K ESTRADIOLestradiol 25 microgram/24 hours patch, 8 1 1 5
MPNP 8761D ESTRADIOLestradiol 25 microgram/24 hours patch, 8 1 1 5
MPNP 8125P ESTRADIOLestradiol 50 microgram/24 hours patch, 4 1 1 5
MPNP 8312L ESTRADIOLestradiol 100 microgram/24 hours patch, 8 1 1 5
MPNP 8765H ESTRADIOLestradiol 100 microgram/24 hours patch, 8 1 1 5
MPNP 8762E ESTRADIOLestradiol 37.5 microgram/24 hours patch, 8 1 1 5
MPNP 8286D ESTRADIOLestradiol 0.1% (1 mg/g) gel, 28 x 1 g sachets 1 1 5
MPNP 1664N ESTRADIOLestradiol valerate 2 mg tablet, 56 1 56 2
MPNP 8244X ESTRADIOL (&) ESTRADIOL + DYDROGESTERONEestradiol 2 mg tablet [14] (&) estradiol 2 mg + dydrogesterone 10 mg tablet [14], 28 1 1 5
MPNP 10146B ESTRADIOL (&) ESTRADIOL + DYDROGESTERONEestradiol 1 mg tablet [14] (&) estradiol 1 mg + dydrogesterone 10 mg tablet [14], 28 1 1 5
MPNP 10142T ESTRADIOL + DYDROGESTERONEestradiol 1 mg + dydrogesterone 5 mg tablet, 28 1 28 5
MPNP 8428N ESTRADIOL + NORETHISTERONE ACETATEestradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8 1 1 5
MPNP 8427M ESTRADIOL + NORETHISTERONE ACETATEestradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8 1 1 5
MPNP 1781R ESTRIOLestriol 0.1% (1 mg/g) cream, 15 g 1 1 1
MPNP 1771F ESTRIOLestriol 500 microgram pessary, 15 1 1 2
MPNP 8748K ETACRYNIC ACIDetacrynic acid 25 mg tablet, 100 2 200 1
MPNP 1414K ETHOSUXIMIDEethosuximide 250 mg/5 mL oral liquid, 200 mL 1 1 5
MPNP 1413J ETHOSUXIMIDEethosuximide 250 mg capsule, 200 1 200 2
MPMWNP 8487Q ETONOGESTRELetonogestrel 68 mg implant, 1 1 1 0
MPNP 8506Q EXEMESTANEexemestane 25 mg tablet, 30 1 30 5
MPNP 10888C EXENATIDEexenatide 2 mg/dose injection: modified release, 4 injection devices 1 4 5
MPNP 3423E EXENATIDEexenatide 5 microgram/dose injection, 60 doses 1 1 5
MPNP 3424F EXENATIDEexenatide 10 microgram/dose injection, 60 doses 1 1 5
MPNP 11408K EZETIMIBEezetimibe 10 mg tablet, 30 1 30 5
MPNP 8757X EZETIMIBEezetimibe 10 mg tablet, 30 1 30 5
MPNP 10393B EZETIMIBE + ATORVASTATINezetimibe 10 mg + atorvastatin 20 mg tablet, 30 1 30 5
MPNP 10377E EZETIMIBE + ATORVASTATINezetimibe 10 mg + atorvastatin 40 mg tablet, 30 1 30 5
MPNP 10392Y EZETIMIBE + ATORVASTATINezetimibe 10 mg + atorvastatin 10 mg tablet, 30 1 30 5
MPNP 10376D EZETIMIBE + ATORVASTATINezetimibe 10 mg + atorvastatin 80 mg tablet, 30 1 30 5
MPNP 9484E EZETIMIBE + SIMVASTATINezetimibe 10 mg + simvastatin 20 mg tablet, 30 1 30 5
MPNP 8882L EZETIMIBE + SIMVASTATINezetimibe 10 mg + simvastatin 80 mg tablet, 30 1 30 5
MPNP 9483D EZETIMIBE + SIMVASTATINezetimibe 10 mg + simvastatin 10 mg tablet, 30 1 30 5
MPNP 8881K EZETIMIBE + SIMVASTATINezetimibe 10 mg + simvastatin 40 mg tablet, 30 1 30 5